RxDoctor Payments DataLook up a doctor →

Wishwdeep Dhillon, MD

Internal Medicine · Gilbert, AZNPI 1417114901

Payments from drug & device makers

$25,407in general payments, 2019–2025

Across 541 payments — averaging $46.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exelixis Inc.$5K
  • AstraZeneca$4K
  • Regeneron$4K
  • Bayer$1K
  • Johnson & Johnson$997
  • Novartis$669
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Exelixis Inc.10$4,966
AstraZeneca(2 entities)43$4,140
Regeneron4$3,969
Bayer16$1,187
Johnson & Johnson(2 entities)62$997
Novartis33$669
Merck37$663
Astellas Pharma US Inc14$616
Pfizer31$532
Regeneron Healthcare Solutions, Inc.5$529
Takeda Pharmaceuticals U.S.A., Inc.13$463
E.r. Squibb & Sons, L.L.C.28$427
AbbVie21$412
Daiichi Sankyo Inc.14$375
Seagen Inc.8$340
Bristol Myers Squibb15$307
Puma Biotechnology, Inc.12$268
Gilead12$261
AVEO Pharmaceuticals, Inc.6$253
Genentech USA, Inc.10$250
Incyte Corporation7$219
Intuitive Surgical2$215
Ipsen Biopharmaceuticals, Inc9$192
Sobi, Inc8$188
Array Biopharma Inc10$173
GSK6$161
Sanofi8$158
Lilly USA, LLC6$140
Foundation Medicine, Inc.2$138
Eisai Inc.6$136
Caris MPI, Inc.2$134
Pharmacyclics LLC, An Abbvie Company2$126
Beone Medicines USA, Inc.4$117
Progenics Pharmaceuticals, Inc.5$108
Tersera Therapeutics LLC5$107
EMD Serono, Inc.4$104
Sanofi-aventis U.S. LLC1$95
Sun Pharmaceutical Industries Inc.5$94
Springworks Therapeutics, Inc.4$79
Amgen4$72
Novocure Inc.4$69
Genmab U.S., Inc.2$68
Aurobindo Pharma USA, Inc.4$65
Mirati Therapeutics, Inc.3$64
Taiho Oncology, Inc.2$62
Visionrt, Inc.1$59
GE HealthCare2$52
Rigel Pharmaceuticals, Inc.2$50
Sumitomo Pharma America, Inc.2$49
Adaptive Biotechnologies Corporation2$39
Jazz Pharmaceuticals Inc.2$36
Teva Pharmaceuticals USA, Inc.2$30
Mylan Institutional Inc.1$30
Stemline Therapeutics Inc.1$28
Beigene USA, Inc.1$28
Iovance Biotherapeutics, Inc.1$25
ADC Therapeutics America, Inc.1$25
Teleflex LLC1$23
Kyowa Kirin, Inc.1$23
Azurity Pharmaceuticals, Inc.1$23

How this compares

$25,407 in reported general payments places this provider in the 95th percentile of 2,212 internal medicine providers in Arizona.

See all internal medicine providers in Arizona →

Medicare billing

Part B allowed, 2024
$146,028
Medicare patients
383
Services billed
1,702

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Gilbert

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →